Stocks
ANI Pharmaceuticals (ANIP) EBITDA margin US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | 29.4% | 13.9% | -0.78% | 15.2% | 22.5% | 11.5% | ||
| Changes by years, y/y, % | -5pp | -15pp | -15pp | +16pp | +7pp | -8.0% | |||
ANI Pharmaceuticals. EBITDA margin, %
ANI Pharmaceuticals. EBITDA margin, changes, pp
ANI Pharmaceuticals (ANIP) EBITDA margin US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| EBITDA margin, % | ? | 23.2% | 18.2% | 21.6% | 17.2% | -9.05% | 11.5% | |
| Changes by years, y/y, % | +6pp | -2pp | -3pp | -7pp | -32pp | |||
| Changes by quarters, q/q, % | -1pp | -5pp | +3pp | -4pp | -26pp | |||
